Literature DB >> 12682471

Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome.

Takeshi Motoyama1, Kazufumi Okamoto, Ichirou Kukita, Masamichi Hamaguchi, Yoshihiro Kinoshita, Hisao Ogawa.   

Abstract

OBJECTIVE: Host response to infection and other forms of tissue injury have been termed systemic inflammatory response syndrome (SIRS). This inflammatory response can frequently be accompanied by oxidative injury in one or more organ systems in the body. The objective of this report was to clarify the possible role of oxidative stress in the development of multiple organ failure (MOF) in patients with SIRS.
DESIGN: Prospective clinical study.
SETTING: Intensive care unit in a university hospital. PATIENTS: A total of 214 consecutive patients (mean age, 57.1 +/- 17.4 yrs; range, 13 to 84 yrs; 148 men and 66 women). At the time of admission, 139 patients fulfilled the clinical criteria for SIRS.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We measured plasma concentrations of thiobarbituric acid reactant substances (TBARS), as an index of oxidative stress, every day from the point of admission to the intensive care unit until discharge or death. Furthermore, all variables of the SIRS score and the Sequential Organ Failure Assessment score were collected every day. At the time of admission, plasma TBARS concentrations in SIRS patients with MOF were significantly higher than those in SIRS patients without MOF (2.3 +/- 0.9 vs. 1.9 +/- 0.6 nmol/mL, p <.01), and there was a significant correlation between plasma TBARS concentration and Sequential Organ Failure Assessment score (r2 =.18, p <.001). Furthermore, the duration of SIRS persistence was significantly associated with the percentage increase in plasma TBARS concentration during SIRS persistence in those patients in whom the duration of SIRS was confirmed (r2 =.73, p <.001). The duration of SIRS was significantly higher in patients who developed MOF than in patients who did not develop MOF (6.9 vs. 3.2 days, p <.001). The percentage increase in plasma TBARS concentration during SIRS was also significantly higher in patients who developed MOF than in patients who did not develop MOF (57.1% vs. 15.8%, p <.001).
CONCLUSIONS: It can be concluded that processes of oxidative stress in connection with continued SIRS may promote the development of MOF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682471     DOI: 10.1097/01.CCM.0000055371.27268.36

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  53 in total

1.  Sepsis: redox mechanisms and therapeutic opportunities.

Authors:  Shyam Biswal; Daniel G Remick
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

2.  Oxidative stress biomarkers in pediatric sepsis: a prospective observational pilot study.

Authors:  Víctor Molina; Bettina von Dessauer; Ramón Rodrigo; Cristian Carvajal
Journal:  Redox Rep       Date:  2016-10-13       Impact factor: 4.412

3.  Antioxidant supplementation and atrial arrhythmias in critically ill trauma patients.

Authors:  Mina F Mirhoseini; Susan E Hamblin; W Paul Moore; Jonathan Pouliot; Judith M Jenkins; Wei Wang; Rameela Chandrasekhar; Bryan R Collier; Mayur B Patel
Journal:  J Surg Res       Date:  2017-10-31       Impact factor: 2.192

4.  Lactoferrin Protects Hyperoxia-Induced Lung and Kidney Systemic Inflammation in an In Vivo Imaging Model of NF-κB/Luciferase Transgenic Mice.

Authors:  Chih-Ching Yen; Wen-Hui Chang; Min-Che Tung; Hsiao-Ling Chen; Hsu-Chung Liu; Chun-Huei Liao; Ying-Wei Lan; Kowit-Yu Chong; Shang-Hsun Yang; Chuan-Mu Chen
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

5.  Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial.

Authors:  Daren K Heyland; Gunnar Elke; Deborah Cook; Mette M Berger; Paul E Wischmeyer; Martin Albert; John Muscedere; Gwynne Jones; Andrew G Day
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-05-05       Impact factor: 4.016

6.  Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study.

Authors:  Wendela L Greven; Jitty M Smit; Johannes H Rommes; Peter E Spronk
Journal:  BMC Clin Pathol       Date:  2010-05-25

7.  A forced titration study of the antioxidant and immunomodulatory effects of Ambrotose AO supplement.

Authors:  Stephen P Myers; Lesley Stevenson; Phillip A Cheras; Joan O'Connor; Lyndon Brooks; Margaret Rolfe; Paul Conellan; Carol Morris
Journal:  BMC Complement Altern Med       Date:  2010-04-30       Impact factor: 3.659

8.  Patients with diabetes in the intensive care unit; not served by treatment, yet protected?

Authors:  Sarah E Siegelaar; J Hans Devries; Joost B Hoekstra
Journal:  Crit Care       Date:  2010-03-01       Impact factor: 9.097

Review 9.  Sepsis: links between pathogen sensing and organ damage.

Authors:  Elliott Crouser; Matthew Exline; Daren Knoell; Mark D Wewers
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock.

Authors:  Shoji Takaki; Naoshi Takeyama; Yuka Kajita; Teru Yabuki; Hiroki Noguchi; Yasuo Miki; Yasusuke Inoue; Takashi Nakagawa; Hiroshi Noguchi
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.